Neonatal infection in premature infants and use of human immunoglobulin

In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 1987-12, Vol.62 (12), p.1252-1256
Main Authors: Conway, S P, Gillies, D R, Docherty, A
Format: Article
Language:English
Subjects:
Bacterial Infections - immunology
Bacterial Infections - prevention & control
Biological and medical sciences
General aspects
Human infectious diseases. Experimental studies and models
Humans
Immunization, Passive
Immunoglobulin G - analysis
Infant, Newborn
Infant, Premature, Diseases - immunology
Infant, Premature, Diseases - prevention & control
Infectious diseases
Medical sciences
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3
cites cdi_FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3
container_end_page 1256
container_issue 12
container_start_page 1252
container_title Archives of disease in childhood
container_volume 62
creator Conway, S P
Gillies, D R
Docherty, A
description In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups who had at least one episode of infection, but the total number of infective episodes was substantially less in the treated group (n = 22) compared with 40 in the non-treated group. Three babies died from overwhelming infection and three babies developed necrotising enterocolitis, all in the group that had not been treated. Serum IgG concentrations were significantly higher in the treated group by the age of 2 weeks but remained consistently below those of full term babies of similar postnatal age. Administration of human immunoglobulin may decrease the severity of infection in premature babies, but alternative regimens may be more successful.
doi_str_mv 10.1136/adc.62.12.1252
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1778641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77937513</sourcerecordid><originalsourceid>FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3</originalsourceid><addsrcrecordid>eNqFkd1rFDEUxYModVt99U0YUAo-zJqb73kRZLEfUGrB6oMvIZPJtFlnkjWZEf3vzbLLon0pXEjI-eXce7gIvQK8BKDivensUpAlbIuTJ2gBTKiaYMaeogXGmNaNUuo5Os55jTEQpegROqKMcuDNAp1fuxjMZIbKh97ZycdQbtUmudFMc3LbZxOmXJnQVXN2Veyr-3k0hRrHOcS7Ibbz4MML9Kw3Q3Yv9-cJ-nr26XZ1UV99Pr9cfbyqWw5sqpWwlhDcN5QZZQnDAIIzLGVngbm-a5QDaCklDacAYDHmHStaQyXIRrT0BH3Y-W7mdnSddWFKZtCb5EeT_uhovP5fCf5e38VfGqRUgkExON0bpPhzdnnSo8_WDYMJLs5ZS1l6caAFfPMAXMc5hRJOg1JCEUKEKtRyR9kUc06uP4wCWG8XpMuCtCAatsVJ-fD63wAHfL-Ror_d6yZbM_TJBOvzAZOKElCiYPUO83lyvw-yST-0kCWAvv620vLm7Hb1nXzRN4V_t-Pbcf3YiH8BJ3Gz9Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1886822268</pqid></control><display><type>article</type><title>Neonatal infection in premature infants and use of human immunoglobulin</title><source>Social Science Premium Collection</source><source>PubMed Central</source><source>Education Collection</source><creator>Conway, S P ; Gillies, D R ; Docherty, A</creator><creatorcontrib>Conway, S P ; Gillies, D R ; Docherty, A</creatorcontrib><description>In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups who had at least one episode of infection, but the total number of infective episodes was substantially less in the treated group (n = 22) compared with 40 in the non-treated group. Three babies died from overwhelming infection and three babies developed necrotising enterocolitis, all in the group that had not been treated. Serum IgG concentrations were significantly higher in the treated group by the age of 2 weeks but remained consistently below those of full term babies of similar postnatal age. Administration of human immunoglobulin may decrease the severity of infection in premature babies, but alternative regimens may be more successful.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/adc.62.12.1252</identifier><identifier>PMID: 3435159</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Bacterial Infections - immunology ; Bacterial Infections - prevention &amp; control ; Biological and medical sciences ; General aspects ; Human infectious diseases. Experimental studies and models ; Humans ; Immunization, Passive ; Immunoglobulin G - analysis ; Infant, Newborn ; Infant, Premature, Diseases - immunology ; Infant, Premature, Diseases - prevention &amp; control ; Infectious diseases ; Medical sciences</subject><ispartof>Archives of disease in childhood, 1987-12, Vol.62 (12), p.1252-1256</ispartof><rights>1988 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Dec 1987</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3</citedby><cites>FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1886822268/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1886822268?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,21365,21381,27911,27912,33598,33599,33864,33865,43720,43867,53778,53780,73976,74152</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7832186$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3435159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conway, S P</creatorcontrib><creatorcontrib>Gillies, D R</creatorcontrib><creatorcontrib>Docherty, A</creatorcontrib><title>Neonatal infection in premature infants and use of human immunoglobulin</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups who had at least one episode of infection, but the total number of infective episodes was substantially less in the treated group (n = 22) compared with 40 in the non-treated group. Three babies died from overwhelming infection and three babies developed necrotising enterocolitis, all in the group that had not been treated. Serum IgG concentrations were significantly higher in the treated group by the age of 2 weeks but remained consistently below those of full term babies of similar postnatal age. Administration of human immunoglobulin may decrease the severity of infection in premature babies, but alternative regimens may be more successful.</description><subject>Bacterial Infections - immunology</subject><subject>Bacterial Infections - prevention &amp; control</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Human infectious diseases. Experimental studies and models</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>Immunoglobulin G - analysis</subject><subject>Infant, Newborn</subject><subject>Infant, Premature, Diseases - immunology</subject><subject>Infant, Premature, Diseases - prevention &amp; control</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNqFkd1rFDEUxYModVt99U0YUAo-zJqb73kRZLEfUGrB6oMvIZPJtFlnkjWZEf3vzbLLon0pXEjI-eXce7gIvQK8BKDivensUpAlbIuTJ2gBTKiaYMaeogXGmNaNUuo5Os55jTEQpegROqKMcuDNAp1fuxjMZIbKh97ZycdQbtUmudFMc3LbZxOmXJnQVXN2Veyr-3k0hRrHOcS7Ibbz4MML9Kw3Q3Yv9-cJ-nr26XZ1UV99Pr9cfbyqWw5sqpWwlhDcN5QZZQnDAIIzLGVngbm-a5QDaCklDacAYDHmHStaQyXIRrT0BH3Y-W7mdnSddWFKZtCb5EeT_uhovP5fCf5e38VfGqRUgkExON0bpPhzdnnSo8_WDYMJLs5ZS1l6caAFfPMAXMc5hRJOg1JCEUKEKtRyR9kUc06uP4wCWG8XpMuCtCAatsVJ-fD63wAHfL-Ror_d6yZbM_TJBOvzAZOKElCiYPUO83lyvw-yST-0kCWAvv620vLm7Hb1nXzRN4V_t-Pbcf3YiH8BJ3Gz9Q</recordid><startdate>19871201</startdate><enddate>19871201</enddate><creator>Conway, S P</creator><creator>Gillies, D R</creator><creator>Docherty, A</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19871201</creationdate><title>Neonatal infection in premature infants and use of human immunoglobulin</title><author>Conway, S P ; Gillies, D R ; Docherty, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Bacterial Infections - immunology</topic><topic>Bacterial Infections - prevention &amp; control</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Human infectious diseases. Experimental studies and models</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>Immunoglobulin G - analysis</topic><topic>Infant, Newborn</topic><topic>Infant, Premature, Diseases - immunology</topic><topic>Infant, Premature, Diseases - prevention &amp; control</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conway, S P</creatorcontrib><creatorcontrib>Gillies, D R</creatorcontrib><creatorcontrib>Docherty, A</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conway, S P</au><au>Gillies, D R</au><au>Docherty, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal infection in premature infants and use of human immunoglobulin</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>1987-12-01</date><risdate>1987</risdate><volume>62</volume><issue>12</issue><spage>1252</spage><epage>1256</epage><pages>1252-1256</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups who had at least one episode of infection, but the total number of infective episodes was substantially less in the treated group (n = 22) compared with 40 in the non-treated group. Three babies died from overwhelming infection and three babies developed necrotising enterocolitis, all in the group that had not been treated. Serum IgG concentrations were significantly higher in the treated group by the age of 2 weeks but remained consistently below those of full term babies of similar postnatal age. Administration of human immunoglobulin may decrease the severity of infection in premature babies, but alternative regimens may be more successful.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><pmid>3435159</pmid><doi>10.1136/adc.62.12.1252</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-9888
ispartof Archives of disease in childhood, 1987-12, Vol.62 (12), p.1252-1256
issn 0003-9888
1468-2044
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1778641
source Social Science Premium Collection; PubMed Central; Education Collection
subjects Bacterial Infections - immunology
Bacterial Infections - prevention & control
Biological and medical sciences
General aspects
Human infectious diseases. Experimental studies and models
Humans
Immunization, Passive
Immunoglobulin G - analysis
Infant, Newborn
Infant, Premature, Diseases - immunology
Infant, Premature, Diseases - prevention & control
Infectious diseases
Medical sciences
title Neonatal infection in premature infants and use of human immunoglobulin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A54%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20infection%20in%20premature%20infants%20and%20use%20of%20human%20immunoglobulin&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Conway,%20S%20P&rft.date=1987-12-01&rft.volume=62&rft.issue=12&rft.spage=1252&rft.epage=1256&rft.pages=1252-1256&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/adc.62.12.1252&rft_dat=%3Cproquest_pubme%3E77937513%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b514t-86cc220f934a8c24011654077dc14efd98e11b332953111c005d4dc19371796b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1886822268&rft_id=info:pmid/3435159&rfr_iscdi=true